United Therapeutics Corporation shares owned by Nicollet Investment Management
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Nicollet Investment Management
from 13F filings
Historical chart of Nicollet Investment Management investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Nicollet Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in United Therapeutics Corporation by Nicollet Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.5M | 5.9k | 419.16 |
| 2025-06-30 | $1.8M | 6.1k | 287.37 |
| 2025-03-31 | $2.0M | 6.3k | 308.28 |
| 2024-12-31 | $2.0M | 5.8k | 352.91 |
| 2024-09-30 | $2.1M | 5.8k | 358.31 |
| 2024-06-30 | $1.8M | 5.8k | 318.61 |
| 2024-03-31 | $1.4M | 5.9k | 229.78 |
| 2023-12-31 | $1.3M | 5.9k | 219.85 |
| 2023-09-30 | $1.3M | 5.8k | 225.81 |
| 2023-06-30 | $1.3M | 5.7k | 220.69 |
| 2023-03-31 | $1.2M | 5.5k | 224.01 |
| 2022-12-31 | $1.6M | 5.8k | 278.07 |
| 2022-09-30 | $1.2M | 5.8k | 209.46 |
| 2022-06-30 | $1.3M | 5.6k | 235.62 |
| 2022-03-31 | $1.0M | 5.6k | 179.39 |
| 2021-12-31 | $1.3M | 5.8k | 216.11 |
| 2021-09-30 | $1.1M | 5.9k | 184.52 |
| 2021-06-30 | $1.1M | 5.9k | 179.40 |
| 2021-03-31 | $998k | 6.0k | 167.31 |
| 2020-12-31 | $909k | 6.0k | 151.83 |
| 2020-09-30 | $584k | 5.8k | 101.07 |
| 2020-06-30 | $718k | 5.9k | 121.08 |
| 2020-03-31 | $558k | 5.9k | 94.82 |
| 2019-12-31 | $514k | 5.8k | 88.16 |
| 2019-09-30 | $482k | 6.0k | 79.74 |
| 2019-06-30 | $468k | 6.0k | 78.13 |
| 2019-03-31 | $707k | 6.0k | 117.44 |
| 2018-12-31 | $656k | 6.0k | 108.97 |
| 2018-09-30 | $776k | 6.1k | 127.84 |
| 2018-06-30 | $665k | 5.9k | 113.19 |
| 2018-03-31 | $652k | 5.8k | 112.41 |
| 2017-12-31 | $858k | 5.8k | 147.93 |
More positions owned by Nicollet Investment Management
View all positions for Nicollet Investment Management
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation